Antibodies Market - Forecast(2024 - 2030)

Report Code: HCR 22428 Report Format: PDF + Excel

Antibodies Market Overview

Antibodies market size is forecast to reach $247.8 billion by 2026, growing at a CAGR of 12.3% during the forecast period 2021-2026. Antibodies are produced in response to antigens by plasma cells. It is also known as immunoglobin and are used as diagnostics as well as therapeutics purposes for various indications of diseases such as macular degeneration, crohn’s disease, psoriasis, and asthma among others. Antibodies are made by B cells and have the ability to bind themselves to specific molecules. It is also used to aid in the identification of molecules. They are capable of identifying unique molecules that have harmful agents. Growth in proteomics & genomics research, increasing research activity, and rising demand for high quality antibodies are the major factors driving the growth of the market. Growing demand for personalized medicine and structure based drug design along with the increasing demand for therapeutic antibodies is set to further enhance the overall market development of the Antibodies Market for the period 2021-2026.

Antibodies Market Report Coverage

The report: “Antibodies Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Antibodies Market.

By Product Type: Monoclonal Antibodies, Polyclonal Antibodies, and Anti Body Drug Complexes
By Indication: Cancer, Autoimmune Diseases, Infectious Diseases, Cardiovascular Diseases, CNS Disorders, and Others
By Technology: Western Blotting, Flow Cytometry, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, and Others
By End Users: Hospitals, Research Institutes, Clinics, and Diagnostic Laboratories
By Application: Proteomics, Drug Development, and Genomics
By Geography: North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, and Rest of South America), and Rest of the World (Middle East, and Africa)

Key Takeaways                                                                                            

  • North America dominated the Antibodies Market in 2020 owing to the development of structure based drug designs and increasing research in the fields of proteomics as well as in genomics. The Antibodies Market scope for different regions will be provided in the final report.
  • Increasing prevalence of chronic disease and increasing applications in oncology, neurobiology, cardiology, and autoimmunology are likely to aid the market growth of the Antibodies Market report.
  • Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Antibodies Market report.
  • High cost of therapeutic antibodies and quality concerns along with the lack of reproducible results is poised to create the hurdles for the Antibodies Market.

Antibodies Market Revenue Share, By Geography, 2020(%)

For More Details on This Report - Request for Sample

 Antibodies Market Segment Analysis – By Product Type

Monoclonal Antibodies held the largest share in the Antibodies Market in 2020 and is estimated to grow at a CAGR 11.4% during the forecast period 2021-2026. This is attributed to the increasing number of research activities that required advanced genetic platforms and are used in development as well as discovery of new therapies to treat cancers. Monoclonal antibodies mimic the immune system’s ability and are laboratory made proteins which fight off harmful pathogens such as viruses. Polyclonal antibodies are critical in antigen purification and histopathological tissue analysis. Growing awareness among individuals regarding treatment of cancer and diagnostic options. They offer stability, great affinity, and favorable storage techniques such as western blotting. Polyclonal antibodies is estimated to register the highest CAGR over the period 2021-2026.

Antibodies Market Segment Analysis – By Technology

Western Blotting held the largest share in the Antibodies Market in 2020 and is estimated to grow at a CAGR 11.1% during the forecast period 2021-2026. This is attributed to the increasing prevalence of diseases with limited treatment options. Western blotting is preferred over other technologies such as flow cytometry for detection of HIV antibodies owing to the greater accuracy that it provides. Immunohistochemistry includes identification of antigens, tumor, enzymes, and tumor cell proliferation among others. Growing awareness among healthcare professionals and patients along with the rise in healthcare expenditure is increasing the demand of flow cytometry. Advantages such as high productivity and sensitivity is also the growth of the segment. Immunohistochemistry is estimated to register the highest CAGR over the period 2021-2026.

Antibodies   Market Segment Analysis – By Geography

North America dominated the Antibodies Market with a major share of 39.7% in 2020. This is attributed to the growing research in the fields of proteomics & genomics, and presence of key players of biopharmaceuticals & biotechnology firms. Increasing prevalence of cardiovascular disease, increasing demand for antibodies for research reproductivity, government investments in improving healthcare expenditures, and increasing development activities to develop effective diagnostic therapy is increasing the growth of the market in this region. However, Asia Pacific is estimated to grow at a higher CAGR during the forecast period 2021-2026 owing to the increasing number of research activities, improving healthcare infrastructure, and increasing pharmaceuticals investments.

Antibodies Market Drivers

Availability of Inexpensive Biosimilar Therapeutic Antibodies

Availability of inexpensive biosimilar therapeutic antibodies is increasing the growth of the Antibodies Market. This is attributed to the increasing treatment seeking rate and patient acceptance. A biosimilar of Remicade was approved by EU in 2013 and is now available all over the world. Recently, EU approved two biosimilar antibodies for rheumatoid antibodies and Novartis AG unlocked the huge market potential for RA in 28 member states of EU. Improvements in production technologies has decreased the manufacturing cost along with high costs of drugs has become an important issue in controlling healthcare cost. Thus, increasing the growth of the Antibodies Market during the forecast period 2021-2026.

Growing Prevalence of Various Forms of Autoimmune Disorders

Growing prevalence of various forms of autoimmune disorders is increasing the growth of the Antibodies Market. Autoimmune disease attacks the healthy cells, organs, and tissues. It can affect any part of the body that weakens the body function and can turn out to be life threatening. These diseases have no cure and sometimes require lifelong treatment to ease the symptoms. Women gets autoimmune disorders at much faster rate than men. Thus, increasing the growth of the Antibodies Market during the forecast period 2021-2026.

Antibodies Market Challenges

High cost of therapeutic antibodies and quality concerns along with the lack of reproducible results

Some of the factors that are set to impede the growth of the Antibodies Market are high cost of therapeutic antibodies and quality concerns along with the lack of reproducible results. The development process of monoclonal antibodies is a complicated procedure as well as a time consuming and there is no standards for their validation reproductibility is set to hinder the growth of the market during the forecast period 2021-2026.

Antibodies Market Landscape

Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Antibodies   Market. In 2020, the Antibodies Market share is consolidated by the top ten players present in the market. The Antibodies  Market, top 10 companies are Abbott Diagnostics, AG Scientific Inc, Bristol Myers Squibb, Novartis AG, Pfizer Inc., and Thermo Fisher Scientific Inc. among others.

Relevant Titles:

Research Antibodies Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2019 - 2024

Report Code: HCR 45602

Antinuclear Antibodies Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2019 - 2024

Report Code: HCR 89073

For more Lifesciences and Healthcare Market reports, please click here

1. Antibodies Market- Overview
    1.1 Definitions and Scope
2. Antibodies Market- Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Product Type
    2.3 Key trends by Indication
    2.4 Key trends by Technology
    2.5 Key trends by End Users
    2.6 Key trends by Application
    2.7 Key trends by Geography
3. Antibodies Market– Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. Antibodies Market- Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Antibodies Market– Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Antibodies Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Antibodies Market– Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Antibodies Market– By Product Type(Market Size –$Million/$Billion)
    8.1 Monoclonal Antibodies
    8.2 Polyclonal Antibodies
    8.3 Anti Body Drug Complexes
9. Antibodies Market– By Indication(Market Size –$Million/$Billion)
    9.1 Cancer
    9.2 Autoimmune Diseases
    9.3 Infectious Diseases
    9.4 Cardiovascular Diseases
    9.5 CND Disorders
    9.6 Others
10. Antibodies Market– By Technology(Market Size –$Million/$Billion)
    10.1 Western Blotting
    10.2 Flow Cytometry
    10.3 Immunohistochemistry
    10.4 Immunofluorescence
    10.5 Immunoprecipitation
    10.6 Others
11. Antibodies Market– By End Users(Market Size –$Million/$Billion)
    11.1 Hospitals
    11.2 Research Institutes
    11.3 Clinics
    11.4 Diagnostic Laboratories
12. Antibodies Market– By Application(Market Size –$Million/$Billion)
    12.1 Proteomics
    12.2 Drug Development
    12.3 Genomics
13. Antibodies Market- By Geography(Market Size –$Million/$Billion)
    13.1 North America
        13.1.1 U.S.
        13.1.2 Mexico
        13.1.3 Canada
    13.2 Europe
        13.2.1 U.K.
        13.2.2 France
        13.2.3 Germany
        13.2.4 Italy
        13.2.5 Spain
        13.2.6 Russia
        13.2.7 Rest of Europe
    13.3 Asia Pacific
        13.3.1 China
        13.3.2 India
        13.3.3 Japan
        13.3.4 South Korea
        13.3.5 Australia & New Zealand
        13.3.6 Rest of Asia Pacific
    13.4 South America
        13.4.1 Brazil
        13.4.2 Argentina
        13.4.3 Rest of South America
    13.5 Rest of the World
        13.5.1 Middle East
        13.5.2 Africa
14. Antibodies Market- Entropy
15. Antibodies Market– Industry/Segment Competition Landscape Premium
    15.1 Market Share Analysis
        15.1.1 Global Market Share – Key Companies
        15.1.2 Market Share by Region – Key companies
        15.1.3 Market Share by Countries – Key Companies
        15.1.4 Best Practices for Companies
16. Antibodies Market– Key Company List by Country Premium Premium
17. Antibodies Market Company Analysis
    17.1 Company 1
    17.2 Company 2
    17.3 Company 3
    17.4 Company 4
    17.5 Company 5
    17.6 Company 6
    17.7 Company 7
    17.8 Company 8
    17.9 Company 9
    17.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global Antibodies Market Analysis, By Product Type Market 2023-2030 ($M)
1.1 Monoclonal antibodies Market 2023-2030 ($M) - Global Industry Research
1.2 Polyclonal antibodies Market 2023-2030 ($M) - Global Industry Research
1.3 Antibody-drug complexes Market 2023-2030 ($M) - Global Industry Research
1.4 Prominent Trends Market 2023-2030 ($M) - Global Industry Research
2.Global Antibodies Market Analysis, By Disease Indication Market 2023-2030 ($M)
2.1 Cardiovascular diseases Market 2023-2030 ($M) - Global Industry Research
2.2 CNS disorders Market 2023-2030 ($M) - Global Industry Research
2.3 Cancer Market 2023-2030 ($M) - Global Industry Research
2.4 Autoimmune Disorders Market 2023-2030 ($M) - Global Industry Research
2.5 Prominent Trends Market 2023-2030 ($M) - Global Industry Research
3.Global Antibodies Market Analysis, By End User Market 2023-2030 ($M)
3.1 Hospitals Market 2023-2030 ($M) - Global Industry Research
3.2 Long-term Care Facilities Market 2023-2030 ($M) - Global Industry Research
3.3 Research institutes Market 2023-2030 ($M) - Global Industry Research
3.4 Prominent Trends Market 2023-2030 ($M) - Global Industry Research
4.Global Competition Landscape Market 2023-2030 ($M)
5.Global Antibodies Market Analysis, By Product Type Market 2023-2030 (Volume/Units)
5.1 Monoclonal antibodies Market 2023-2030 (Volume/Units) - Global Industry Research
5.2 Polyclonal antibodies Market 2023-2030 (Volume/Units) - Global Industry Research
5.3 Antibody-drug complexes Market 2023-2030 (Volume/Units) - Global Industry Research
5.4 Prominent Trends Market 2023-2030 (Volume/Units) - Global Industry Research
6.Global Antibodies Market Analysis, By Disease Indication Market 2023-2030 (Volume/Units)
6.1 Cardiovascular diseases Market 2023-2030 (Volume/Units) - Global Industry Research
6.2 CNS disorders Market 2023-2030 (Volume/Units) - Global Industry Research
6.3 Cancer Market 2023-2030 (Volume/Units) - Global Industry Research
6.4 Autoimmune Disorders Market 2023-2030 (Volume/Units) - Global Industry Research
6.5 Prominent Trends Market 2023-2030 (Volume/Units) - Global Industry Research
7.Global Antibodies Market Analysis, By End User Market 2023-2030 (Volume/Units)
7.1 Hospitals Market 2023-2030 (Volume/Units) - Global Industry Research
7.2 Long-term Care Facilities Market 2023-2030 (Volume/Units) - Global Industry Research
7.3 Research institutes Market 2023-2030 (Volume/Units) - Global Industry Research
7.4 Prominent Trends Market 2023-2030 (Volume/Units) - Global Industry Research
8.Global Competition Landscape Market 2023-2030 (Volume/Units)
9.North America Antibodies Market Analysis, By Product Type Market 2023-2030 ($M)
9.1 Monoclonal antibodies Market 2023-2030 ($M) - Regional Industry Research
9.2 Polyclonal antibodies Market 2023-2030 ($M) - Regional Industry Research
9.3 Antibody-drug complexes Market 2023-2030 ($M) - Regional Industry Research
9.4 Prominent Trends Market 2023-2030 ($M) - Regional Industry Research
10.North America Antibodies Market Analysis, By Disease Indication Market 2023-2030 ($M)
10.1 Cardiovascular diseases Market 2023-2030 ($M) - Regional Industry Research
10.2 CNS disorders Market 2023-2030 ($M) - Regional Industry Research
10.3 Cancer Market 2023-2030 ($M) - Regional Industry Research
10.4 Autoimmune Disorders Market 2023-2030 ($M) - Regional Industry Research
10.5 Prominent Trends Market 2023-2030 ($M) - Regional Industry Research
11.North America Antibodies Market Analysis, By End User Market 2023-2030 ($M)
11.1 Hospitals Market 2023-2030 ($M) - Regional Industry Research
11.2 Long-term Care Facilities Market 2023-2030 ($M) - Regional Industry Research
11.3 Research institutes Market 2023-2030 ($M) - Regional Industry Research
11.4 Prominent Trends Market 2023-2030 ($M) - Regional Industry Research
12.North America Competition Landscape Market 2023-2030 ($M)
13.South America Antibodies Market Analysis, By Product Type Market 2023-2030 ($M)
13.1 Monoclonal antibodies Market 2023-2030 ($M) - Regional Industry Research
13.2 Polyclonal antibodies Market 2023-2030 ($M) - Regional Industry Research
13.3 Antibody-drug complexes Market 2023-2030 ($M) - Regional Industry Research
13.4 Prominent Trends Market 2023-2030 ($M) - Regional Industry Research
14.South America Antibodies Market Analysis, By Disease Indication Market 2023-2030 ($M)
14.1 Cardiovascular diseases Market 2023-2030 ($M) - Regional Industry Research
14.2 CNS disorders Market 2023-2030 ($M) - Regional Industry Research
14.3 Cancer Market 2023-2030 ($M) - Regional Industry Research
14.4 Autoimmune Disorders Market 2023-2030 ($M) - Regional Industry Research
14.5 Prominent Trends Market 2023-2030 ($M) - Regional Industry Research
15.South America Antibodies Market Analysis, By End User Market 2023-2030 ($M)
15.1 Hospitals Market 2023-2030 ($M) - Regional Industry Research
15.2 Long-term Care Facilities Market 2023-2030 ($M) - Regional Industry Research
15.3 Research institutes Market 2023-2030 ($M) - Regional Industry Research
15.4 Prominent Trends Market 2023-2030 ($M) - Regional Industry Research
16.South America Competition Landscape Market 2023-2030 ($M)
17.Europe Antibodies Market Analysis, By Product Type Market 2023-2030 ($M)
17.1 Monoclonal antibodies Market 2023-2030 ($M) - Regional Industry Research
17.2 Polyclonal antibodies Market 2023-2030 ($M) - Regional Industry Research
17.3 Antibody-drug complexes Market 2023-2030 ($M) - Regional Industry Research
17.4 Prominent Trends Market 2023-2030 ($M) - Regional Industry Research
18.Europe Antibodies Market Analysis, By Disease Indication Market 2023-2030 ($M)
18.1 Cardiovascular diseases Market 2023-2030 ($M) - Regional Industry Research
18.2 CNS disorders Market 2023-2030 ($M) - Regional Industry Research
18.3 Cancer Market 2023-2030 ($M) - Regional Industry Research
18.4 Autoimmune Disorders Market 2023-2030 ($M) - Regional Industry Research
18.5 Prominent Trends Market 2023-2030 ($M) - Regional Industry Research
19.Europe Antibodies Market Analysis, By End User Market 2023-2030 ($M)
19.1 Hospitals Market 2023-2030 ($M) - Regional Industry Research
19.2 Long-term Care Facilities Market 2023-2030 ($M) - Regional Industry Research
19.3 Research institutes Market 2023-2030 ($M) - Regional Industry Research
19.4 Prominent Trends Market 2023-2030 ($M) - Regional Industry Research
20.Europe Competition Landscape Market 2023-2030 ($M)
21.APAC Antibodies Market Analysis, By Product Type Market 2023-2030 ($M)
21.1 Monoclonal antibodies Market 2023-2030 ($M) - Regional Industry Research
21.2 Polyclonal antibodies Market 2023-2030 ($M) - Regional Industry Research
21.3 Antibody-drug complexes Market 2023-2030 ($M) - Regional Industry Research
21.4 Prominent Trends Market 2023-2030 ($M) - Regional Industry Research
22.APAC Antibodies Market Analysis, By Disease Indication Market 2023-2030 ($M)
22.1 Cardiovascular diseases Market 2023-2030 ($M) - Regional Industry Research
22.2 CNS disorders Market 2023-2030 ($M) - Regional Industry Research
22.3 Cancer Market 2023-2030 ($M) - Regional Industry Research
22.4 Autoimmune Disorders Market 2023-2030 ($M) - Regional Industry Research
22.5 Prominent Trends Market 2023-2030 ($M) - Regional Industry Research
23.APAC Antibodies Market Analysis, By End User Market 2023-2030 ($M)
23.1 Hospitals Market 2023-2030 ($M) - Regional Industry Research
23.2 Long-term Care Facilities Market 2023-2030 ($M) - Regional Industry Research
23.3 Research institutes Market 2023-2030 ($M) - Regional Industry Research
23.4 Prominent Trends Market 2023-2030 ($M) - Regional Industry Research
24.APAC Competition Landscape Market 2023-2030 ($M)
25.MENA Antibodies Market Analysis, By Product Type Market 2023-2030 ($M)
25.1 Monoclonal antibodies Market 2023-2030 ($M) - Regional Industry Research
25.2 Polyclonal antibodies Market 2023-2030 ($M) - Regional Industry Research
25.3 Antibody-drug complexes Market 2023-2030 ($M) - Regional Industry Research
25.4 Prominent Trends Market 2023-2030 ($M) - Regional Industry Research
26.MENA Antibodies Market Analysis, By Disease Indication Market 2023-2030 ($M)
26.1 Cardiovascular diseases Market 2023-2030 ($M) - Regional Industry Research
26.2 CNS disorders Market 2023-2030 ($M) - Regional Industry Research
26.3 Cancer Market 2023-2030 ($M) - Regional Industry Research
26.4 Autoimmune Disorders Market 2023-2030 ($M) - Regional Industry Research
26.5 Prominent Trends Market 2023-2030 ($M) - Regional Industry Research
27.MENA Antibodies Market Analysis, By End User Market 2023-2030 ($M)
27.1 Hospitals Market 2023-2030 ($M) - Regional Industry Research
27.2 Long-term Care Facilities Market 2023-2030 ($M) - Regional Industry Research
27.3 Research institutes Market 2023-2030 ($M) - Regional Industry Research
27.4 Prominent Trends Market 2023-2030 ($M) - Regional Industry Research
28.MENA Competition Landscape Market 2023-2030 ($M)

LIST OF FIGURES

1.US Antibodies Market Revenue, 2023-2030 ($M)
2.Canada Antibodies Market Revenue, 2023-2030 ($M)
3.Mexico Antibodies Market Revenue, 2023-2030 ($M)
4.Brazil Antibodies Market Revenue, 2023-2030 ($M)
5.Argentina Antibodies Market Revenue, 2023-2030 ($M)
6.Peru Antibodies Market Revenue, 2023-2030 ($M)
7.Colombia Antibodies Market Revenue, 2023-2030 ($M)
8.Chile Antibodies Market Revenue, 2023-2030 ($M)
9.Rest of South America Antibodies Market Revenue, 2023-2030 ($M)
10.UK Antibodies Market Revenue, 2023-2030 ($M)
11.Germany Antibodies Market Revenue, 2023-2030 ($M)
12.France Antibodies Market Revenue, 2023-2030 ($M)
13.Italy Antibodies Market Revenue, 2023-2030 ($M)
14.Spain Antibodies Market Revenue, 2023-2030 ($M)
15.Rest of Europe Antibodies Market Revenue, 2023-2030 ($M)
16.China Antibodies Market Revenue, 2023-2030 ($M)
17.India Antibodies Market Revenue, 2023-2030 ($M)
18.Japan Antibodies Market Revenue, 2023-2030 ($M)
19.South Korea Antibodies Market Revenue, 2023-2030 ($M)
20.South Africa Antibodies Market Revenue, 2023-2030 ($M)
21.North America Antibodies By Application
22.South America Antibodies By Application
23.Europe Antibodies By Application
24.APAC Antibodies By Application
25.MENA Antibodies By Application